ENvue Medical Inc
FEED
8 hedge funds and large institutions have $251K invested in ENvue Medical Inc in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
54% more capital invested
Capital invested by funds: $163K → $251K (+$88.2K)
33% more funds holding
Funds holding: 6 → 8 (+2)
0.06% more ownership
Funds ownership: 0.08% → 0.13% (+0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$93.8K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$14K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$5.53K |
| 4 |
Renaissance Technologies
New York
|
+$3.35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.02K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$145 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $171K | +$93.8K | +1,290 | +104% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $18.5K | – | – | – |
|
|
3
Renaissance Technologies
New York
| $16.3K | +$3.35K | +46 | +23% |
|
|
4
Citadel Advisors
Miami,
Florida
| $14.6K | +$5.53K | +76 | +54% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $14K | -$145 | -2 | -1% |
|
|
TSS
6
Two Sigma Securities
New York
| $13K | +$14K | +193 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $3.71K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $910 | +$1.02K | +14 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $15 | – | – | – |
|
FEED Hedge Fund Activity: Q3 2024 in Review
8 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q3 2024, worth a combined $251K — up 54% from $163K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FEED positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, adding an estimated $93.8K. The largest seller was Geode Capital Management, cutting an estimated $145.
- 8 institutional investors held ENvue Medical Inc (FEED) as of Q3 2024, up from 6 in Q2 2024.
- Funds reported $251K of ENvue Medical Inc stock for Q3 2024, up 54% quarter-over-quarter.
- 2 funds opened new ENvue Medical Inc positions in Q3 2024 and 0 closed out, a net change of +2 holders.
- The largest ENvue Medical Inc buyer in Q3 2024 was Armistice Capital, an estimated $93.8K added.
- The largest ENvue Medical Inc seller in Q3 2024 was Geode Capital Management, an estimated $145 sold.
Based on aggregated 13F filings for Q3 2024.